The City of Hope Admits to Testing Ivemectin Versus Cancer

ByPrimary Researcher

Executive Summary

  • The medical establishment is very much opposed to using Ivermectin to treat cancer.
  • This is why it is so surprising to see an article at the City of Hope cancer center about using Ivermectin for this purpose.

Introduction

After so many medical authorities advising against Ivermectin even for things other than cancer and simply denying the research on the benefits of Ivermectin, it was surprising to see the topic covered on the City of Hope’s website.

The City of Hope

The following quotes are from the article Novel Drug Combo Shows Promise Against Triple-Negative Breast Cancer.

Important Point #1: Checkpoint Inhibitor With Ivermectin

City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to successfully treat triple-negative breast cancer in preclinical research, according to a study published March 2 in npj Breast Cancer journal. (Ivermectin is also currently being used in clinical trials to treat and prevent COVID-19.)

This article was written in March 2021 — which is before the war on Ivermectin really kicked into high gear.

Triple-negative breast cancer is a difficult type of cancer to treat because the tumor cells lack three key proteins — receptors for the hormones estrogen and progesterone and the protein HER2. Doctors now treat breast cancer based on targeting these three key proteins, but without them, triple-negative breast cancer has limited treatment options.

Checkpoint inhibitors are a type of immunotherapy. These are bad value for patients. However, the Ivermectin will be effective.

Important Point #2: Checkpoint Inhibitors Have Not Worked Against Breast Cancer

First, ivermectin turned “cold tumors,” which have little to no T cells, or immune cells, into “hot tumors,” or tumors with a high number of T cells. Turning the tumors into hot tumors then enabled anti-PD1 monoclonal antibodies to work. The checkpoint inhibitors blocked the PD1 protein, helping the immune system and, specifically, T cells, do what they’re designed to do: eradicate cancer.

“For the most part, checkpoint inhibitors have not worked in treating breast cancer,” Lee said.

This is an amazing quote. Other oncologists will be angry at Dr. Lee for admitting that checkpoint inhibitors have not worked against breast cancer.

Important Point #3: Ivermectin Needs a Checkpoint Inhibitor?

“This is the first time we can show that by adding an inexpensive, existing safe drug, you can make breast cancer treatable with immune checkpoint therapy. It’s the two drugs working together that is the magic. Either drug alone has almost zero effect, but together they have a powerful synergistic effect.”

I disagree that Ivermectin works with checkpoint inhibitors or needs checkpoint inhibitors to be effective against cancer — or that any synergistic effect is involved. The benefits from this treatment come from Ivermectin, no checkpoint inhibitors. However, Dr. Lee must use Ivermectin with another approved drug to use it. That is the only way such a study could get approved.